![Bleeding associated with co-administration of clopidogrel and ACEi in patients undergoing PCI and DAPT - Atherosclerosis Bleeding associated with co-administration of clopidogrel and ACEi in patients undergoing PCI and DAPT - Atherosclerosis](https://www.atherosclerosis-journal.com/cms/asset/c984bdc6-c32d-4529-83b3-22b8d15e968b/ga1.jpg)
Bleeding associated with co-administration of clopidogrel and ACEi in patients undergoing PCI and DAPT - Atherosclerosis
![A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4291c6945a0948035be6295ea5b505b1fcab2212/4-Table1-1.png)
A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar
![A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents - ScienceDirect A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021915019314637-fx1.jpg)
A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents - ScienceDirect
![Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients | Scientific Reports Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-09679-8/MediaObjects/41598_2022_9679_Fig1_HTML.png)
Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients | Scientific Reports
![Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea | Scientific Reports Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-97989-8/MediaObjects/41598_2021_97989_Fig1_HTML.png)
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea | Scientific Reports
![of death or hospitalization for heart failure or reinfarction during... | Download Scientific Diagram of death or hospitalization for heart failure or reinfarction during... | Download Scientific Diagram](https://www.researchgate.net/publication/276922692/figure/tbl1/AS:669141119803431@1536547083992/of-death-or-hospitalization-for-heart-failure-or-reinfarction-during-clopidogrel-therapy.png)
of death or hospitalization for heart failure or reinfarction during... | Download Scientific Diagram
![Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial - The Lancet Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2000996739/2003696725/gr1.gif)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial - The Lancet
![Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials - The Lancet Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials - The Lancet](https://www.thelancet.com/cms/attachment/d0393cea-6776-483c-af66-c759e442193a/gr1_lrg.jpg)
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials - The Lancet
![A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4291c6945a0948035be6295ea5b505b1fcab2212/2-Figure1-1.png)
A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar
![A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4291c6945a0948035be6295ea5b505b1fcab2212/5-Table3-1.png)
A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors | Semantic Scholar
Prescription Prevalence and Continuing Medication Use for Secondary Prevention After Myocardial Infarction (16.12.2011)
![JCDD | Free Full-Text | Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials JCDD | Free Full-Text | Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials](https://pub.mdpi-res.com/jcdd/jcdd-08-00123/article_deploy/html/images/jcdd-08-00123-ag.png?1633657137)